KYORIN Pharmaceutical Co., Ltd.
杏林製薬株式会社
Valuation
Fundamental ratios for the latest reported period.
Ticker: 4569
FY2025 · 2026-03-31
| Gross margin | 40.9% |
| Operating margin | 2.8% |
| Net margin | 2.7% |
| Return on equity | 2.6% |
| Return on assets | 1.8% |
| Revenue growth (YoY) | -2.9% |
| EPS (basic) | ¥60.03 |
| EPS growth (YoY) | -62.0% |
| Current ratio | 4.60x |
| Equity ratio | 67.1% |
| Book value / share | ¥2,479.28 |
| Free cash flow | 2,517 M |